Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Non-Current Assets: 2019-2025

Historic Non-Current Assets for Benitec Biopharma (BNTC) over the last 5 years, with Mar 2025 value amounting to $1.2 million.

  • Benitec Biopharma's Non-Current Assets rose 89.42% to $1.2 million in Q1 2025 from the same period last year, while for Mar 2025 it was $1.2 million, marking a year-over-year increase of 89.42%. This contributed to the annual value of $536,000 for FY2024, which is 27.07% down from last year.
  • As of Q1 2025, Benitec Biopharma's Non-Current Assets stood at $1.2 million, which was up 237.75% from $355,000 recorded in Q4 2024.
  • Over the past 5 years, Benitec Biopharma's Non-Current Assets peaked at $1.5 million during Q3 2021, and registered a low of $355,000 during Q4 2024.
  • Over the past 3 years, Benitec Biopharma's median Non-Current Assets value was $633,000 (recorded in 2024), while the average stood at $657,778.
  • In the last 5 years, Benitec Biopharma's Non-Current Assets plummeted by 40.11% in 2023 and then spiked by 89.42% in 2025.
  • Over the past 5 years, Benitec Biopharma's Non-Current Assets (Quarterly) stood at $1.3 million in 2021, then tumbled by 30.70% to $930,000 in 2022, then plummeted by 40.11% to $557,000 in 2023, then crashed by 36.27% to $355,000 in 2024, then skyrocketed by 89.42% to $1.2 million in 2025.
  • Its last three reported values are $1.2 million in Q1 2025, $355,000 for Q4 2024, and $439,000 during Q3 2024.